ACTA1 and cancer: Our findings validate and extend our earlier results [9], where we demonstrated using the same dual‐marker FAP/αSMA IHC assay and Random Forest‐based machine learning model that stromal FAP is associated with both BCR‐free survival and cancer‐specific survival.